Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Lung Cancer Mortality and Polynuclear Aromatic Hydrocarbons: A Case-Cohort Study of Aluminum Production Workers in Arvida, Quebec, Canada *

The authors report the results of a case-cohort study of 338 lung cancer deaths in 1950-1988 and a random sample (sub-cohort) of 1,138 from among 16,297 men who had worked at least one year between 1950 and 1979 in manual jobs at a large aluminum production plant. In the past, certain workers were exposed to substantial quantities of coal tar pitch volatiles, a mixture known to include polynuclear (polycyclic) aromatic hydrocarbons, and thus suspected to be capable of causing lung cancer. After they controlled for the effects of smoking, the authors found that rate ratios rose with cumulative exposure to coal tar pitch volatiles measured as benzene-soluble material to 2.25 (95% confidence interval (Cl) 1.50–3.38) at 10–19 mg/m3-years benzene-soluble matter, but did not rise further at higher exposures. The data are compatible with a linear relation with benzene-soluble matter (rate ratio (RR) = 1 + 0.031 mg/m3-years benzenesoluble matter). This model predicts a rate ratio of 1.25, and lifelong excess risk of 2.2%, after 40 years exposure at the current hygiene standard (0.2 mg/m3). A curved relation (RR = 1 + 0.098 mg/m3-years benzene-soluble matter 0.7) fitted somewhat better. Under this model, the predicted risks after this exposure are higher: 1.42 and 3.8%. The data are compatible with both additive and multiplicative models for the combined effect of smoking and coal tar pitch volatiles.

* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 10-27-2008
Authors: Ben Armstrong, Claude Tremblay, Dalsu Baris and Gilles Theriault
Source: American Journal of Epidemiology Vol. 139, No. 3: 250-262